Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Our Tests
Ataraxis Breast
Overview
Recurrence Risk (RISK)
Chemotherapy benefit (CTX)
Neoadjuvant response (NEO)
Ataraxis Breast
About Us
News
Evidence
Careers
Contact Us
Copyright © 2025, ataraxis.ai, All Rights Reserved.
Homepage
AI Research
Research
Overview
Causality
Representation Learning
Survival Analysis
Ataraxis Breast
Our Tests
Ataraxis Breast
Overview
Recurrence risk (RISK)
Chemotherapy benefit (CTX)
Neoadjuvant response (NEO)
Ataraxis Breast
About Us
News
Evidence
Careers
Ordering Portal
Contact Us
Ordering Portal
Contact Us
Ordering Portal
Ataraxis lands $20.4 million Series A to accelerate clinical deployment of AI precision medicine
Read More
November 27, 2024
Media Coverage
Ataraxis AI Aims to Address Gaps in Molecular Testing with AI Digital Pathology Tests
